1. Home
  2. CLCO vs EOLS Comparison

CLCO vs EOLS Comparison

Compare CLCO & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cool Company Ltd.

CLCO

Cool Company Ltd.

HOLD

Current Price

$9.67

Market Cap

516.5M

Sector

N/A

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$5.92

Market Cap

444.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLCO
EOLS
Founded
2018
2012
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
516.5M
444.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CLCO
EOLS
Price
$9.67
$5.92
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.50
AVG Volume (30 Days)
244.3K
891.1K
Earning Date
02-26-2026
11-05-2025
Dividend Yield
6.22%
N/A
EPS Growth
N/A
N/A
EPS
1.12
N/A
Revenue
$327,762,000.00
$285,823,000.00
Revenue This Year
$4.24
$14.24
Revenue Next Year
N/A
$21.77
P/E Ratio
$8.67
N/A
Revenue Growth
N/A
15.10
52 Week Low
$4.51
$5.71
52 Week High
$10.00
$17.12

Technical Indicators

Market Signals
Indicator
CLCO
EOLS
Relative Strength Index (RSI) 39.37 29.49
Support Level $9.61 $6.57
Resistance Level $10.00 $6.80
Average True Range (ATR) 0.06 0.27
MACD -0.03 -0.12
Stochastic Oscillator 13.46 6.23

Price Performance

Historical Comparison
CLCO
EOLS

About CLCO Cool Company Ltd.

Cool Co Ltd is a LNG shipping company. The company is engaged in the acquisition, ownership, operation and chartering of liquefied natural gas (LNG) carriers (LNGCs), and the operation of third party fleets under management agreements. The company manages its business through a single operating and reporting segment, the LNG carrier market.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: